Milquantel 2.5mg/25.0mg Tablets for Small Dogs & Puppies
Milquantel 2.5mg/25.0mg Tablets for Small Dogs & Puppies
Authorised
- Milbemycin oxime
- Praziquantel
Product identification
Medicine name:
Milquantel 2.5mg/25.0mg Tablets for Small Dogs & Puppies
Milquantel 2,5 mg/25 mg compresse per cani di taglia piccola e cuccioli che pesano almeno 0,5 kg
Active substance:
- Milbemycin oxime
- Praziquantel
Target species:
-
Dog
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Milbemycin oxime2.50/milligram(s)1.00Tablet
-
Praziquantel25.00/milligram(s)1.00Tablet
Pharmaceutical form:
-
Tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP54AB51
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Italy
Available in:
-
Italy
Package description:
- Blister packs consisting of cold formed OPA_Al_PVC foil and aluminium foil. Box with 12 blisters of 4 tablets
- Blister packs consisting of cold formed OPA_Al_PVC foil and aluminium foil. Box with 1 blister of 4 tablets
- Blister packs consisting of cold formed OPA_Al_PVC foil and aluminium foil. Box with 1 blister of 2 tablets
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- KRKA tovarna zdravil d.d. Novo mesto
Marketing authorisation date:
Manufacturing sites for batch release:
- KRKA tovarna zdravil d.d. Novo mesto
Responsible authority:
- Ministry Of Health
Authorisation number:
- 105104
Date of authorisation status change:
Reference member state:
-
Netherlands
Procedure number:
- NL/V/0259/001
Concerned member states:
-
France
-
Italy
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
English (PDF)
Download Published on: 4/04/2024
Italian (PDF)
Published on: 9/03/2022
